Sequence & Structure:
MKAARFVLRSAGSLNGAGLVPREVEHFSRYSPSPLSMKQLLDFGSENACERTSFAFLRQELPVRLANILKEIDILPTQLVNTSSVQLVKSWYIQSLMDLVEFHEKSPDDQKALSDFVDTLIKVRNRHHNVVPTMAQGIIEYKDACTVDPVTNQNLQYFLDRFYMNRISTRMLMNQHILIFSDSQTGNPSHIGSIDPNCDVVAVVQDAFECSRMLCDQYYLSSPELKLTQVNGKFPDQPIHIVYVPSHLHHMLFELFKNAMRATVEHQENQPSLTPIEVIVVLGKEDLTIKISDRGGGVPLRIIDRLFSYTYSTAPTPVMDNSRNAPLAGFGYGLPISRLYAKYFQGDLNLYSLSGYGTDAIIYLKALSSESIEKLPVFNKSAFKHYQMSSEADDWCIPSREPKNLAKEVAM
Select PDB:
Target | Drug name | MOA | Phase | Status | Disease | Source |
---|---|---|---|---|---|---|
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 3 | Completed | lactic acidosis | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 3 | Active, not recruiting | pyruvate dehydrogenase deficiency | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Completed | head and neck squamous cell carcinoma | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Recruiting | glioblastoma multiforme | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Completed | glioblastoma multiforme | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Completed | heart disease | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Completed | lactic acidosis | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Terminated | breast cancer | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 2 | Terminated | lung cancer | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 1 | Withdrawn | glioblastoma multiforme | ClinicalTrials |
PDK4 | SODIUM DICHLOROACETATE | Pyruvate dehydrogenase kinase inhibitor | 1 | Completed | pulmonary arterial hypertension | ClinicalTrials |
Note: Only show clinically investigational or approved drugs with protein targets.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.